Home » Newsletters » BioWorld

BioWorld

Oct. 7, 1992

View Archived Issues

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 16, 2025.
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.
FDA wants more data for Otsuka’s sNDA in PTSD
BioWorld
The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with...